Updated:
Serpentine Ventures
Serpentine Ventures is a venture capital based in Zurich, founded 2019; the Altss profile covers its classification, headquarters, registration, AUM band, and...
Serpentine Ventures
Thousands of pitchdecks and entrepreneur meetings have sharpened our instincts individually and as a team. We’re confident to trust them.
General information
Firm type
Venture Capital
Year founded
2019
AUM
Undisclosed
Location
Region
Europe
Country
Switzerland
City
Zurich
Corporate office
Förrlibuckstrasse 190, 8005 Zurich, Switzerland
Principals
Oliver Walzer
Founding Partner & COO
Craig Cooper
Partner
Michael Stucky
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Serpentine Ventures?
Oliver Walzer is the Founding Partner and COO, and he operates alongside partners Craig Cooper and Michael Stucky. The firm does not publicly detail a separate investment committee structure. Day-to-day investment decisions appear led by this small partnership group.
How does Serpentine Ventures source proprietary deal flow?
Serpentine emphasizes early conviction, investing in companies before incorporation in some cases—MindMetrix is cited as an example. The firm states it evaluates thousands of pitchdecks and entrepreneur meetings to sharpen instincts. Specific sourcing channels beyond its Swiss network are not publicly described.
Is Serpentine Ventures a single-family office or a venture capital firm?
Serpentine is a venture asset manager, not a single-family office. It raises and deploys thematic venture funds, including a dedicated Diabetes Venture Fund, alongside generalist early-stage capital. It does not manage a single family's wealth.
Does Serpentine Ventures participate in fund commitments or only direct deals?
The firm invests directly into companies from seed through growth stages. There is no public evidence of Serpentine acting as a limited partner in other venture funds. Its structure as an asset manager suggests it operates direct investment vehicles.
What investment stages does Serpentine Ventures target?
Serpentine invests across the lifecycle: pre-seed (before incorporation), seed, start-up, early stage, expansion/late stage, and growth. It also executes PIPEs and spin-off transactions. The portfolio includes companies at every stage from pre-launch to Series A and beyond.
Which sectors does Serpentine Ventures explicitly avoid?
Serpentine does not publish an exclusion list. Its portfolio reveals no investments in extractive industries, military technology, tobacco, or consumer lending. The concentration is on deep tech, climate, health, and enterprise software, suggesting a de facto focus on innovation-driven sectors rather than formal negative screening.
What is Serpentine Ventures' posture on co-investments alongside external GPs?
Serpentine co-invests alongside other venture capital firms as standard practice. In the Luna Health Series A, it invested alongside lead Vensana Capital. RAAAM's round was led by NXP Semiconductors with Serpentine participating as an existing investor. The firm does not advertise a formal co-investment program for limited partners.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: